Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Migraine

  Free Subscription


24.05.2021

1 Acta Neurol Scand
2 Cephalalgia
1 Headache
1 JAMA
1 Lancet Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neurol Scand

  1. SILVESTRO M, Tessitore A, Scotto di Clemente F, Battista G, et al
    Refractory migraine profile in CGRP-monoclonal antibodies scenario.
    Acta Neurol Scand. 2021 May 21. doi: 10.1111/ane.13472.
    PubMed         Abstract available


    Cephalalgia

  2. COHEN-BARAK O, Radivojevic A, Jones A, Fiedler-Kelly J, et al
    Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach.
    Cephalalgia. 2021 May 17:3331024211007789. doi: 10.1177/03331024211007789.
    PubMed         Abstract available

  3. GANTENBEIN AR, Agosti R, Gobbi C, Flugel D, et al
    Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study.
    Cephalalgia. 2021 May 17:3331024211014616. doi: 10.1177/03331024211014616.
    PubMed         Abstract available


    Headache

  4. LIPTON RB, Dodick DW, Ailani J, McGill L, et al
    Patient-identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient-centered outcome.
    Headache. 2021 May 20. doi: 10.1111/head.14120.
    PubMed         Abstract available


    JAMA

  5. ROBBINS MS
    Diagnosis and Management of Headache: A Review.
    JAMA. 2021;325:1874-1885.
    PubMed         Abstract available


    Lancet Neurol

  6. SAMARASEKERA U
    Michael Moskowitz: solving the puzzle of migraine.
    Lancet Neurol. 2021 May 17. pii: S1474-4422(21)00141.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: